Compliant Labeling of Active Implantable Medical Devices: When Precision and Quality Ensure Life
Active implantable medical devices (AIMDs), such as pacemakers or neurostimulatory systems, perform vital functions in the human body. Accordingly, the requirements for quality, safety, and reliability are high—including in labeling, which is central to unique identification and traceability.
Strict regulatory requirements
AIMDs belong to the highest risk class and are subject to international regulations such as the MDR, FDA, and the ISO 14708 standard. These require that markings be permanent, unique, and legible. In addition, they must ensure that relevant information—such as serial numbers or UDI codes—is available at all times to guarantee compliance and patient safety.
Marking requirements in practice
In implementation, this means that markings must not only be precise and durable but also biocompatible and functionally neutral. The labeling must not impair the material or the performance of the implant. At the same time, it must remain reliably legible for many years, even under demanding conditions.
Risks of inadequate labeling?
Faulty or non-standard markings can have far-reaching consequences—from regulatory deviations to product recalls. Thus, the quality of the labeling directly influences the approval capability and ultimately patient safety.
Further information on this topic can be found in the FOBA blog.
